TherapeuticsMD (TXMD) Receivables - Net (2010 - 2022)
TherapeuticsMD (TXMD) recorded Receivables - Net of $32.16 million in Q3 2022, down 14.0% from $37.4 million a year earlier and down 29.8% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Receivables - Net (2010 - 2022) Analysis & Trends
At the end of FY2021, TherapeuticsMD reported Receivables - Net of $36.18 million, up 11.7% from FY2020.
- Annual Receivables - Net has increased for four straight years, with a five-year compound annual growth rate of 51.7% (FY2016 to FY2021).
- Across earlier years, Receivables - Net came in at $32.38 million in FY2020 (+32.7%), $24.4 million in FY2019 (+120.5%), $11.06 million in FY2018 (+155.6%) and $4.33 million in FY2017 (-3.8%).
- The Q3 2022 figure is the lowest quarterly Receivables - Net since Q3 2020.
- On a year-over-year basis, Receivables - Net rose in seven of the last eight quarters, with growth averaging 34.2%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 226.8% in Q2 2019, against a decline of 14.0% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $45.8 million (Q2 2022), $35.41 million (Q1 2022) and $36.18 million (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 32.16 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Mar 31, 2022 | 35.41 Mn |
| Dec 31, 2021 | 36.18 Mn |
| Sep 30, 2021 | 37.40 Mn |
| Jun 30, 2021 | 33.48 Mn |
| Mar 31, 2021 | 33.72 Mn |
| Dec 31, 2020 | 32.38 Mn |
| Sep 30, 2020 | 24.06 Mn |
| Jun 30, 2020 | 18.29 Mn |
| Mar 31, 2020 | 20.66 Mn |
| Dec 31, 2019 | 24.40 Mn |
| Sep 30, 2019 | 15.32 Mn |
| Jun 30, 2019 | 18.38 Mn |
| Mar 31, 2019 | 14.94 Mn |
| Dec 31, 2018 | 11.06 Mn |
| Sep 30, 2018 | 12.80 Mn |
| Jun 30, 2018 | 5.63 Mn |
| Mar 31, 2018 | 5.10 Mn |
| Dec 31, 2017 | 4.33 Mn |
API Access
TherapeuticsMD Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();